Y2/Y4 selective receptor agonists for therapeutic interventions

Details for Australian Patent Application No. 2005224027 (hide)

Owner 7TM PHARMA A/S

Inventors Schwartz, Thue

Agent Davies Collison Cave

Pub. Number AU-B-2005224027

PCT Pub. Number WO2005/089790

Priority 60/585,964 06.07.04 US; 0503111.7 14.02.05 GB; 60/558,932 01.04.04 US; PA 2004 00436 17.03.04 DK

Filing date 17 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 26 May 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/089790 Priority application(s): WO2005/089790

26 May 2011 Application Accepted

  Published as AU-B-2005224027

22 September 2011 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224028-Y4 selective receptor agonists for therapeutic interventions

2005224026-Y2 selective receptor agonists for therapeutic interventions